RE: Three clear value drivers for Avacta13 Dec 2023 10:47
T'll probably become the new standard of care for Sarcoma chemotherapy, but it'll take time and a definitive phase 2 trial.
That's just how it works. Not FUD, realism based on the facts.
Thorn, anyone with half a brain knows there will be a phase 2 trial. I'm not sure what you are getting at?
Alan now needs to articulate, honestly how he intends to finance phase 2. Thats what the markets wants to know,